Gregory W. Albers

Publications

• Clinical and radiographic natural history of cervical artery dissections. Schwartz NE, Vertinsky AT, Hirsch KG, Albers GW. J Stroke Cerebrovasc Dis. 2009 Nov-Dec; 18 (6): 416-23
• Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M. Stroke. 2009; 40 (7): 2594-600
• Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Gold GE, Bammer R, Marks MP, Albers GW. Stroke. 2009; 40 (10): 3245-51
• Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke With LMWH (PREVAIL) study. Kase CS, Albers GW, Bladin C, Fieschi C, Gabbai AA, O'Riordan W, Pineo GF. Stroke. 2009; 40 (11): 3532-40
• Improving dynamic susceptibility contrast MRI measurement of quantitative cerebral blood flow using corrections for partial volume and nonlinear contrast relaxivity: A xenon computed tomographic comparative study. Zaharchuk G, Bammer R, Straka M, Newbould RD, Rosenberg J, Olivot JM, Mlynash M, Lansberg MG, Schwartz NE, Marks MM, Albers GW, Moseley ME. J Magn Reson Imaging. 2009; 30 (4): 743-52
• Use of MRI to estimate the therapeutic window in acute stroke: is perfusion-weighted imaging/diffusion-weighted imaging mismatch an EPITHET for salvageable ischemic brain tissue? Toth G, Albers GW. Stroke. 2009; 40 (1): 333-5
• Relationships between cerebral perfusion and reversibility of acute diffusion lesions in DEFUSE: insights from RADAR. Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Stroke. 2009; 40 (5): 1692-7
• Yield of combined perfusion and diffusion MR imaging in hemispheric TIA. Mlynash M, Olivot JM, Tong DC, Lansberg MG, Eyngorn I, Kemp S, Moseley ME, Albers GW. Neurology. 2009; 72 (13): 1127-33
• Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW. Stroke. 2009; 40 (2): 469-75
• Mismatch-Based Delayed Thrombolysis. A Meta-Analysis. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, Lees KR. Stroke. 2009
• Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, Kasner S, Lew R, Nash M, Perez J, Rymer M, Schellinger P, Schneider D, Schwab S, Veltkamp R, Walker M, Streeter J. Stroke. 2009; 40 (4): 1359-64
• Hyperfibrinogenemia and functional outcome from acute ischemic stroke. del Zoppo GJ, Levy DE, Wasiewski WW, Pancioli AM, Demchuk AM, Trammel J, Demaerschalk BM, Kaste M, Albers GW, Ringelstein EB. Stroke. 2009; 40 (5): 1687-91
• Prognostic value of brain diffusion-weighted imaging after cardiac arrest. Wijman CA, Mlynash M, Caulfield AF, Hsia AW, Eyngorn I, Bammer R, Fischbein N, Albers GW, Moseley M. Ann Neurol. 2009; 65 (4): 394-402
• Perfusion MRI (Tmax and MTT) correlation with xenon CT cerebral blood flow in stroke patients. Olivot JM, Mlynash M, Zaharchuk G, Straka M, Bammer R, Schwartz N, Lansberg MG, Moseley ME, Albers GW. Neurology. 2009; 72 (13): 1140-5
• Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Chest. 2008; 133 (6 Suppl): 630S-669S
• Chapter 64 Antithrombotic agents for stroke prevention. Schwartz NE, Diener HC, Albers GW. Handb Clin Neurol. 2008: 94 1277-94
• Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Marks MP, Olivot JM, Kemp S, Lansberg MG, Bammer R, Wechsler LR, Albers GW, Thijs V. Radiology. 2008; 249 (2): 614-23
• Rapid assessment and intervention at specialist outpatient clinics-time for a new standard in TIA care? Albers GW, Nat Clin Pract Neurol. 2008; 4 (4): 184-5
• Use of antiplatelet agents to prevent stroke: what is the role for combinations of medications? Schwartz NE, Albers GW. Curr Neurol Neurosci Rep. 2008; 8 (1): 29-34
• Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Schlaug G, Bammer R, Marks MP, Albers GW. Stroke. 2008; 39 (8): 2257-63
• Comparison of multidetector CT angiography and MR imaging of cervical artery dissection. Vertinsky AT, Schwartz NE, Fischbein NJ, Rosenberg J, Albers GW, Zaharchuk G. AJNR Am J Neuroradiol. 2008; 29 (9): 1753-60
• The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, Kemp S, Albers GW. Stroke. 2008; 39 (9): 2491-6
• Is there a role for combinations of antiplatelet agents in stroke prevention? Schwartz NE, Albers GW. Curr Treat Options Neurol. 2007; 9 (6): 442-50
• Warfarin prevails for stroke prevention in atrial fibrillation--even in octogenarians. Albers GW, Lancet Neurol. 2007; 6 (10): 844-6
• Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Fiehler J, Albers GW, Boulanger JM, Derex L, Gass A, Hjort N, Kim JS, Liebeskind DS, Neumann-Haefelin T, Pedraza S, Rother J, Rothwell P, Rovira A, Schellinger PD, Trenkler J. Stroke. 2007; 38 (10): 2738-44
• Perfusion mapping with multiecho multishot parallel imaging EPI. Newbould RD, Skare ST, Jochimsen TH, Alley MT, Moseley ME, Albers GW, Bammer R. Magn Reson Med. 2007; 58 (1): 70-81
• Transient isolated vertigo secondary to an acute stroke of the cerebellar nodulus. Schwartz NE, Venkat C, Albers GW. Arch Neurol. 2007; 64 (6): 897-8
• Neurological picture. Acute strokes in the setting of a persistent primitive trigeminal artery. Schwartz NE, Albers GW. J Neurol Neurosurg Psychiatry. 2007; 78 (7): 745
• Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Lansberg MG, Thijs VN, Hamilton S, Schlaug G, Bammer R, Kemp S, Albers GW. Stroke. 2007; 38 (6): 1826-30
• Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Lansberg MG, Albers GW, Wijman CA. Cerebrovasc Dis. 2007; 24 (1): 1-10
• The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Sherman DG, Albers GW, Bladin C, Fieschi C, Gabbai AA, Kase CS, O'Riordan W, Pineo GF. Lancet. 2007; 369 (9570): 1347-55
• Clinical multishot DW-EPI through parallel imaging with considerations of susceptibility, motion, and noise. Skare S, Newbould RD, Clayton DB, Albers GW, Nagle S, Bammer R. Magn Reson Med. 2007; 57 (5): 881-90
• Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Arch Intern Med. 2007; 167 (3): 239-45
• Can the ESPRIT results end the antiplatelet battle between neurologists and cardiologists? Albers GW, Nat Clin Pract Cardiovasc Med. 2007; 4 (3): 118-9
• Secondary stroke prevention with ximelagatran versus warfarin in patients with atrial fibrillation: pooled analysis of SPORTIF III and V clinical trials. Akins PT, Feldman HA, Zoble RG, Newman D, Spitzer SG, Diener HC, Albers GW. Stroke. 2007; 38 (3): 874-80
• Intravenous alteplase for ischaemic stroke. Albers GW, Olivot JM. Lancet. 2007; 369 (9558): 249-50
• Identifying systematic errors in quantitative dynamic-susceptibility contrast perfusion imaging by high-resolution multi-echo parallel EPI. Jochimsen TH, Newbould RD, Skare ST, Clayton DB, Albers GW, Moseley ME, Bammer R. NMR Biomed. 2007; 20 (4): 429-38
• Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW. Stroke. 2007; 38 (8): 2275-8
• National Stroke Association guidelines for the management of transient ischemic attacks. Johnston SC, Nguyen-Huynh MN, Schwarz ME, Fuller K, Williams CE, Josephson SA, Hankey GJ, Hart RG, Levine SR, Biller J, Brown RD, Sacco RL, Kappelle LJ, Koudstaal PJ, Bogousslavsky J, Caplan LR, van Gijn J, Algra A, Rothwell PM, Adams HP, Albers GW. Ann Neurol. 2006; 60 (3): 301-13
• Safety and tolerability of arundic acid in acute ischemic stroke. Pettigrew LC, Kasner SE, Albers GW, Gorman M, Grotta JC, Sherman DG, Funakoshi Y, Ishibashi H. J Neurol Sci. 2006; 251 (1-2): 50-6
• Acute cerebrovascular syndrome: time for new terminology for acute brain ischemia. Albers GW, Nat Clin Pract Cardiovasc Med. 2006; 3 (10): 521
• Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Ann Neurol. 2006; 60 (5): 508-17
• Trials and tribulations of noninferiority: the ximelagatran experience. Albers GW, Diener HC, Frison L, Grind M, Horrow J, Nevinson M, Olsson SB, Partridge S, Petersen P, Vahanian A, Halperin JL. J Am Coll Cardiol. 2006; 48 (5): 1058; author reply 1059
• MRI characteristics of cerebral air embolism from a venous source. Caulfield AF, Lansberg MG, Marks MP, Albers GW, Wijman CA. Neurology. 2006; 66 (6): 945-6
• Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W. Stroke. 2006; 37 (5): 1227-31
• Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Circulation. 2006; 113 (10): e409-49
• Mechanical thrombectomy following intravenous thrombolysis in the treatment of acute stroke. Lansberg MG, Fields JD, Albers GW, Jayaraman MV, Do HM, Marks MP. Arch Neurol. 2005; 62 (11): 1763-5
• Clinical importance of microbleeds in patients receiving IV thrombolysis. Kakuda W, Thijs VN, Lansberg MG, Bammer R, Wechsler L, Kemp S, Moseley ME, Marks MP, Albers GW. Neurology. 2005; 65 (8): 1175-8
• The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. Stroke. 2005; 36 (1): 66-73
• Oral antiplatelet therapy. Bernstein RA, Albers GW. JAMA. 2005; 293 (7): 793-4; author reply 794-5
• Mechanical thrombectomy for acute stroke. Versnick EJ, Do HM, Albers GW, Tong DC, Marks MP. AJNR Am J Neuroradiol. 2005; 26 (4): 875-9
• Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW. AJNR Am J Neuroradiol. 2005; 26 (3): 525-30
• Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. Albers GW, Diener HC, Frison L, Grind M, Nevinson M, Partridge S, Halperin JL, Horrow J, Olsson SB, Petersen P, Vahanian A. JAMA. 2005; 293 (6): 690-8
• Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Fisher M, Albers GW, Donnan GA, Furlan AJ, Grotta JC, Kidwell CS, Sacco RL, Wechsler LR. Stroke. 2005; 36 (8): 1808-13
• Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Chest. 2004; 126 (3 Suppl): 483S-512S
• A review of published TIA treatment recommendations. Albers GW, Neurology. 2004; 62 (8 Suppl 6): S26-8
• Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. Rockson SG, Albers GW. J Am Coll Cardiol. 2004; 43 (6): 929-35
• Diffusion-weighted MR imaging in acute ischemia: value of apparent diffusion coefficient and signal intensity thresholds in predicting tissue at risk and final infarct size. Na DG, Thijs VN, Albers GW, Moseley ME, Marks MP. AJNR Am J Neuroradiol. 2004; 25 (8): 1331-6
• Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Chest. 2004; 126 (3 Suppl): 429S-456S
• Proceedings of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004; 126 (3 Suppl): 172S-696S
• Discussion: Reconsideration of TIA terminology and definitions. Easton JD, Albers GW, Caplan LR, Saver JL, Sherman DG. Neurology. 2004; 62 (8 Suppl 6): S29-34
• Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging. Thijs VN, Somford DM, Bammer R, Robberecht W, Moseley ME, Albers GW. Stroke. 2004; 35 (1): 94-8
• Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials. Albers GW, Am J Manag Care. 2004; 10 (14 Suppl): S462-9; discussion S469-73
• Optimizing oral anticoagulation in managed care. Caro JJ, Albers GW. Am J Manag Care. 2004; 10 (14 Suppl): S474-7
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Lancet. 2004; 363 (9411): 768-74
• Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Smith WS, Johnston SC, Skalabrin EJ, Weaver M, Azari P, Albers GW, Gress DR. Neurology. 2003; 60 (9): 1424-8
• Transient ischemic attack--proposal for a new definition. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG. N Engl J Med. 2002; 347 (21): 1713-6
• ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Albers GW, Clark WM, Madden KP, Hamilton SA. Stroke. 2002; 33 (2): 493-5
• Patient safety in trials of therapy for acute ischemic stroke. Goldstein LB, Albers GW. JAMA. 2002; 287 (8): 987
• Clinical and radiological correlates of reduced cerebral blood flow measured using magnetic resonance imaging. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Albers GW. Arch Neurol. 2002; 59 (2): 233-8
• Relationship between severity of MR perfusion deficit and DWI lesion evolution. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Neurology. 2001; 57 (7): 1205-11
• Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. Liu AY, Do HM, Albers GW, Lopez JR, Steinberg GK, Marks MP. AJNR Am J Neuroradiol. 2001; 22 (8): 1597-601
• Advances in intravenous thrombolytic therapy for treatment of acute stroke. Albers GW, Neurology. 2001; 57 (5 Suppl 2): S77-81
• Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Lansberg MG, O'Brien MW, Tong DC, Moseley ME, Albers GW. Arch Neurol. 2001; 58 (4): 613-7
• Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. Lansberg MG, Thijs VN, O'Brien MW, Ali JO, de Crespigny AJ, Tong DC, Moseley ME, Albers GW. AJNR Am J Neuroradiol. 2001; 22 (4): 637-44
• Antithrombotic and thrombolytic therapy for ischemic stroke. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Chest. 2001; 119 (1 Suppl): 300S-320S
• Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. Albers GW, Goldstein LB, Hall D, Lesko LM. JAMA. 2001; 286 (21): 2673-82
• Antithrombotic therapy in atrial fibrillation. Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Chest. 2001; 119 (1 Suppl): 194S-206S
• Potential utility of diffusion-weighted imaging in venous infarction. Bernstein R, Albers GW. Arch Neurol. 2001; 58 (10): 1538-9
• A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP, Jackson CM, Pullicino P. N Engl J Med. 2001; 345 (20): 1444-51
• Antithrombotic therapy for prevention and treatment of ischemic stroke. Albers GW, J Thromb Thrombolysis. 2001; 12 (1): 19-22
• Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients? Albers GW, Amarenco P. Stroke. 2001; 32 (12): 2948-9
• Recent advances in stroke management. Albers GW, Alberts MJ, Broderick JP, Lyden PD, Sacco RL. J Stroke Cerebrovasc Dis. 2000 May-Jun; 9 (3): 95-105
• Basilar artery stenosis: clinical and neuroradiographic features. Woolfenden AR, Tong DC, Norbash AM, Ali AO, Marks MP, O'Brien MW, Albers GW. J Stroke Cerebrovasc Dis. 2000 Mar-Apr; 9 (2): 57-63
• Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E. Cerebrovasc Dis. 2000 Jan-Feb; 10 (1): 39-43
• Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients. Albers GW, Lansberg MG, Norbash AM, Tong DC, O'Brien MW, Woolfenden AR, Marks MP, Moseley ME. Neurology. 2000; 54 (8): 1562-7
• Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: potential use in guiding thrombolytic therapy. Tong DC, Albers GW. Curr Opin Neurol. 2000; 13 (1): 45-50
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. JAMA. 2000; 283 (9): 1145-50
• New magnetic resonance imaging methods for cerebrovascular disease: emerging clinical applications. Neumann-Haefelin T, Moseley ME, Albers GW. Ann Neurol. 2000; 47 (5): 559-70
• Clinical problem-solving. Eyes wide open. Morton-Bours EC, Jacobs MB, Albers GW. N Engl J Med. 2000; 343 (1): 50-5
• Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Thijs VN, Albers GW. Neurology. 2000; 55 (4): 490-7
• Advantages of adding diffusion-weighted magnetic resonance imaging to conventional magnetic resonance imaging for evaluating acute stroke. Lansberg MG, Norbash AM, Marks MP, Tong DC, Moseley ME, Albers GW. Arch Neurol. 2000; 57 (9): 1311-6
• Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Stroke. 2000; 31 (11): 2597-602
• Supplement to the AHA guidelines for the management of transient ischemic attacks Hughes RL, Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Stroke. 2000; 31 (4): 983-91
• The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Clark WM, Albers GW, Madden KP, Hamilton S. Stroke. 2000; 31 (4): 811-6
• Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J. Stroke. 2000; 31 (2): 347-54
• Addendum to the supplement to the guidelines for the management of transient ischemic attacks Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Stroke. 2000; 31 (4): 1001
• Comparison of diffusion-weighted MRI and CT in acute stroke. Lansberg MG, Albers GW, Beaulieu C, Marks MP. Neurology. 2000; 54 (8): 1557-61
• Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients? Albers GW, Neurology. 2000; 54 (5): 1022-8
• Headache with neurological deficits and CSF lymphocytosis: A transient ischemic attack mimic. Lansberg MG, Woolfenden AR, Norbash AM, Smith DB, Albers GW. J Stroke Cerebrovasc Dis. 1999 Jan-Feb; 8 (1): 42-4
• Emerging evidence for inflammation in conditions frequently affecting older adults: report of a symposium. Hamerman D, Berman JW, Albers GW, Brown DL, Silver D. J Am Geriatr Soc. 1999; 47 (8): 1016-25
• A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Tong DC, Albers GW, Yenari MA, Marks MP. Stroke. 1999; 30 (9): 1974-5
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. JAMA. 1999; 282 (21): 2019-26
• AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: A statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Albers GW, Hart RG, Lutsep HL, Newell DW, Sacco RL. Stroke. 1999; 30 (11): 2502-11
• Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Fisher M, Albers GW. Neurology. 1999; 52 (9): 1750-6
• Risk factors for stroke and primary prevention of stroke in atrial fibrillation. Laupacis A, Singer D, Jacobsen A, Dunn M, Dalen J, Albers G. J Thromb Thrombolysis. 1999; 7 (1): 21-6
• Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy. Woolfenden AR, Albers GW, Steinberg GK, Hahn JS, Johnston DC, Farrell K. Pediatrics. 1999; 103 (2): 505-8
• Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke. Albers GW, Clark WM, Atkinson RP, Madden K, Data JL, Whitehouse MJ. Stroke. 1999; 30 (3): 508-13
• MRI abnormalities associated with partial status epilepticus. Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. Neurology. 1999; 52 (5): 1021-7
• Outcome of angioplasty for atherosclerotic intracranial stenosis. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Stroke. 1999; 30 (5): 1065-9
• Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Neurology. 1999; 52 (9): 1792-8
• Cerebral amyloid angiopathy with unilateral hemorrhages, mass effect, and meningeal enhancement. Morton-Bours EC, Skalabrin EJ, Albers GW. Neurology. 1999; 53 (1): 233-4
• Antithrombotic management of atrial fibrillation for stroke prevention in older people. Tong DC, Albers GW. Clin Geriatr Med. 1999; 15 (4): 645-62
• Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Albers GW, Stroke. 1999; 30 (10): 2230-7
• Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Beaulieu C, de Crespigny A, Tong DC, Moseley ME, Albers GW, Marks MP. Ann Neurol. 1999; 46 (4): 568-78
• Antiplatelet therapy: new foundations for optimal treatment decisions. Albers GW, Tijssen JG. Neurology. 1999; 53 (7 Suppl 4): S25-31
• Acute Ischemic Stroke. Chan BP, Albers GW. Curr Treat Options Neurol. 1999; 1 (2): 83-96
• Thrombolysis with reteplase, an unglycosylated plasminogen activator variant, in experimental embolic stroke. Yenari MA, Lee LK, Beaulieu C, Sun GH, Kunis D, Chang D, Albers GW, Moseley ME, Steinberg GK. J Stroke Cerebrovasc Dis. 1998 May-Jun; 7 (3): 179-86
• Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Neurology. 1998; 50 (4): 864-70
• Angiographically defined primary angiitis of the CNS: is it really benign? Woolfenden AR, Tong DC, Marks MP, Ali AO, Albers GW. Neurology. 1998; 51 (1): 183-8
• Progressive facial hemiatrophy: abnormality of intracranial vasculature. Woolfenden AR, Tong DC, Norbash AM, Albers GW. Neurology. 1998; 50 (6): 1915-7
• Ethical standards in phase 1 trials of neuroprotective agents for stroke therapy. Albers GW, Zivin JA, Choi DW. Stroke. 1998; 29 (8): 1493-4
• Antithrombotic therapy in atrial fibrillation. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Chest. 1998; 114 (5 Suppl): 579S-589S
• Choice of antithrombotic therapy for stroke prevention in atrial fibrillation: warfarin, aspirin, or both? Albers GW, Arch Intern Med. 1998; 158 (14): 1487-91
• Antithrombotic and thrombolytic therapy for ischemic stroke. Albers GW, Easton JD, Sacco RL, Teal P. Chest. 1998; 114 (5 Suppl): 683S-698S
• Diffusion-weighted MRI for evaluation of acute stroke. Albers GW, Neurology. 1998; 51 (3 Suppl 3): S47-9
• Rationale for early intervention in acute stroke. Albers GW, Am J Cardiol. 1997; 80 (4C): 4D-10D; discussion 35D-39D
• American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke. Mohr JP, Albers GW, Amarenco P, Babikian VL, Biller J, Brey RL, Coull B, Easton JD, Gomez CR, Helgason CM, Kase CS, Pullicino PM, Turpie AG. Stroke. 1997; 28 (7): 1501-6
• Use of fluid attenuating inversion recovery, MR angiogram, and diffusion-weighted MRI techniques for assessment of pontine infarction in a patient treated with radiation therapy for pituitary neoplasm. Graef LM, Lutsep HL, Norbash A, Albers GW. Neurology. 1997; 48 (2): 540-2
• Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals. Albers GW, Bittar N, Young L, Hattemer CR, Gandhi AJ, Kemp SM, Hall EA, Morton DJ, Yim J, Vlasses PH. Neurology. 1997; 48 (6): 1598-604
• Intravenous thrombolytic therapy in acute stroke. Tong DC, Yenari MA, Albers GW. Vasc Med. 1997; 2 (1): 51-60
• Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME. Ann Neurol. 1997; 41 (5): 574-80
• Management of acute ischemic stroke. An update for primary care physicians. Albers GW, West J Med. 1997; 166 (4): 253-62
• Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke. Yenari MA, de Crespigny A, Palmer JT, Roberts S, Schrier SL, Albers GW, Moseley ME, Steinberg GK. J Cereb Blood Flow Metab. 1997; 17 (4): 401-11
• Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed. Davis SM, Albers GW, Diener HC, Lees KR, Norris J. Lancet. 1997; 349 (9044): 32
• MELAS: Clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Clark JM, Marks MP, Adalsteinsson E, Spielman DM, Shuster D, Horoupian D, Albers GW. Neurology. 1996; 46 (1): 223-7
• MR and cerebrospinal fluid enzymes as sensitive indicators of subclinical cerebral injury after open-heart valve replacement surgery. Steinberg GK, De La Paz R, Mitchell RS, Bell TE, Albers GW. AJNR Am J Neuroradiol. 1996; 17 (2): 205-12; discussion 213-5
• Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Marks MP, de Crespigny A, Lentz D, Enzmann DR, Albers GW, Moseley ME. Radiology. 1996; 199 (2): 403-8
• Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH. Arch Intern Med. 1996; 156 (20): 2311-6
• Safety of heparin in acute ischemic stroke. Hart RG, Boop BS, Tong DC, Yenari MA, Albers GW. Neurology. 1996; 46 (2): 589; author reply 589-91
• Anticoagulant therapy monitoring with international normalized ratio at US academic health centers. Yim JM, Albers GW, Vlasses PH. Ann Pharmacother. 1996; 30 (12): 1390-5
• Anticoagulation/platelet inhibition for atrial fibrillation. Albers GW, Hirsh J. Coron Artery Dis. 1995; 6 (2): 129-35
• Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM. Stroke. 1995; 26 (2): 254-8
• Antithrombotic agents in cerebral ischemia. Albers GW, Am J Cardiol. 1995; 75 (6): 34B-38B
• Neurologic complications following chiropractic manipulation: a survey of California neurologists. Lee KP, Carlini WG, McCormick GF, Albers GW. Neurology. 1995; 45 (6): 1213-5
• Antithrombotic therapy in atrial fibrillation. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Chest. 1995; 108 (4 Suppl): 352S-359S
• Vertical gaze palsies from medial thalamic infarctions without midbrain involvement. Clark JM, Albers GW. Stroke. 1995; 26 (8): 1467-70
• Transcranial Doppler-detected microemboli in patients with acute stroke. Tong DC, Albers GW. Stroke. 1995; 26 (9): 1588-92
• Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. Gage BF, Cardinalli AB, Albers GW, Owens DK. JAMA. 1995; 274 (23): 1839-45
• Detection of carotid stenosis. From NASCET results to clinical practice. Chang YJ, Golby AJ, Albers GW. Stroke. 1995; 26 (8): 1325-8
• Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. Comess KA, DeRook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. J Am Coll Cardiol. 1994; 23 (7): 1598-603
• Atrial fibrillation and stroke. Three new studies, three remaining questions. Albers GW, Arch Intern Med. 1994; 154 (13): 1443-8
• Incidence of transcranial Doppler-detected cerebral microemboli in patients referred for echocardiography. Tong DC, Bolger A, Albers GW. Stroke. 1994; 25 (11): 2138-41
• Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Feinberg WM, Albers GW, Barnett HJ, Biller J, Caplan LR, Carter LP, Hart RG, Hobson RW, Kronmal RA, Moore WS. Circulation. 1994; 89 (6): 2950-65
• Transesophageal echocardiographic findings in stroke subtypes. Albers GW, Comess KA, DeRook FA, Bracci P, Atwood JE, Bolger A, Hotson J. Stroke. 1994; 25 (1): 23-8
• Anticoagulation and atrial fibrillation. Atwood JE, Albers GW. Herz. 1993; 18 (1): 27-38
• Laboratory monitoring of oral anticoagulant therapy: are we being misled? Albers GW, Neurology. 1993; 43 (3 Pt 1): 468-70
• Treatment of tardive dyskinesia with vitamin E. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ. Am J Psychiatry. 1992; 149 (6): 773-7
• Antithrombotic therapy in atrial fibrillation. Laupacis A, Albers G, Dunn M, Feinberg W. Chest. 1992; 102 (4 Suppl): 426S-433S
• Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Albers GW, Sáenz RE, Moses JA. Clin Neuropharmacol. 1992; 15 (6): 509-14
• Failure of high-dose heparin to prevent recurrent cardioembolic strokes in a pregnant patient with a mechanical heart valve. Golby AJ, Bush EC, DeRook FA, Albers GW. Neurology. 1992; 42 (11): 2204-6
• Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Lindsey JW, Albers GW, Steinman L. Ann Neurol. 1992; 32 (3): 407-9
• Role of ticlopidine for prevention of stroke. Albers GW, Stroke. 1992; 23 (6): 912-6
• Do NMDA antagonists prevent neuronal injury? Yes. Albers GW, Goldberg MP, Choi DW. Arch Neurol. 1992; 49 (4): 418-20
• Transesophageal echocardiography in the evaluation of stroke. DeRook FA, Comess KA, Albers GW, Popp RL. Ann Intern Med. 1992; 117 (11): 922-32
• Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Albers GW, Sherman DG, Gress DR, Paulseth JE, Petersen P. Ann Neurol. 1991; 30 (4): 511-8
• Stroke prevention in nonvalvular atrial fibrillation. Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ. Ann Intern Med. 1991; 115 (9): 727-36
• Lacunar stroke: relationship between atypical etiology and infarct size? Albers GW, Arch Neurol. 1991; 48 (12): 1215
• Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Albers GW, Sáenz RE, Moses JA, Choi DW. Stroke. 1991; 22 (8): 1075-7
• Intensity of anticoagulant treatment and risk of intracerebral hematoma. Albers GW, Stroke. 1990; 21 (12): 1758
• Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia. Albers GW, Clin Neuropharmacol. 1990; 13 (3): 177-97
• Nifedipine versus propranolol for the initial prophylaxis of migraine. Albers GW, Simon LT, Hamik A, Peroutka SJ. Headache. 1989; 29 (4): 215-8
• N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Albers GW, Goldberg MP, Choi DW. Ann Neurol. 1989; 25 (4): 398-403
• Treatment response in malignant optic glioma of adulthood. Albers GW, Hoyt WF, Forno LS, Shratter LA. Neurology. 1988; 38 (7): 1071-4
• Left ventricular tumor masquerading as multiple sclerosis. Albers GW, Avalos SM, Weinrich M. Arch Neurol. 1987; 44 (7): 779-80
• Calcium chloride for treatment of subcutaneous lipomas in dogs. Albers GW, Theilen GH. J Am Vet Med Assoc. 1985; 186 (5): 492-4